BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 30380530)

  • 21. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss.
    Cvorovic L; Jovanovic MB; Milutinovic Z; Arsovic N; Djeric D
    Otol Neurotol; 2013 Aug; 34(6):1021-6. PubMed ID: 23820795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of combination therapy for idiopathic sudden sensorineural hearing loss.
    Jung da J; Park JH; Jang JH; Lee KY
    Laryngoscope; 2016 Aug; 126(8):1871-6. PubMed ID: 26972103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Hyperbaric Oxygen on Idiopathic Sudden Sensorineural Hearing Loss and Its Correlation with Treatment Course: Prospective Clinical Research.
    Huang C; Tan G; Xiao J; Wang G
    Audiol Neurootol; 2021; 26(6):479-486. PubMed ID: 34814132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
    Sun RX; Zhao Y; Liu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):972-977. PubMed ID: 29771066
    [No Abstract]   [Full Text] [Related]  

  • 25. The Effectiveness of Hyperbaric Oxygen Therapy in Severe Idiopathic Sudden Sensorineural Hearing Loss.
    Ahn Y; Seo YJ; Lee YS
    J Int Adv Otol; 2021 May; 17(3):215-220. PubMed ID: 34100745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss.
    Yang CH; Wu RW; Hwang CF
    Otol Neurotol; 2013 Oct; 34(8):1411-6. PubMed ID: 24005170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late?
    Amarillo E; Navarro A; Hernández-García E; Plaza G
    Acta Otolaryngol; 2019 Jul; 139(7):632-635. PubMed ID: 31124732
    [No Abstract]   [Full Text] [Related]  

  • 28. Addition of intratympanic steroid or hyperbaric oxygen treatment to systemic steroid treatment in sudden idiopathic sensorineural hearing loss treatment, and long-term results of salvage treatment.
    Keseroğlu K; Toptaş G; Uluat A; Bayir Ö; Çadalli Tatar E; Saylam G; Korkmaz MH; Özdek A
    Turk J Med Sci; 2020 Feb; 50(1):177-183. PubMed ID: 31865663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratympanic steroid injection for sudden sensorineural hearing loss: Impact of injection interval on therapeutic efficacy.
    Kwak MY; Yang CJ; Shim HJ; Song CI; Kim JY; Lee IW; Jung SW; Lim HW; Kwon JK; Lee JH; Choi J; An YS; Lee KY; Chung JW
    Auris Nasus Larynx; 2020 Dec; 47(6):982-989. PubMed ID: 32650961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of multimodality approach to sudden hearing loss.
    Naiboğllu B; Külekçi S; Sürmeli M; Verim A; Kalaycik Ertugay Ç; İhvan Ö; Şeneldir L; Zer Toros S
    Kulak Burun Bogaz Ihtis Derg; 2015; 25(2):77-81. PubMed ID: 25935057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.
    Rauch SD; Halpin CF; Antonelli PJ; Babu S; Carey JP; Gantz BJ; Goebel JA; Hammerschlag PE; Harris JP; Isaacson B; Lee D; Linstrom CJ; Parnes LS; Shi H; Slattery WH; Telian SA; Vrabec JT; Reda DJ
    JAMA; 2011 May; 305(20):2071-9. PubMed ID: 21610239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study.
    Tong B; Niu K; Ku W; Xie W; Dai Q; Hellström S; Duan M
    Audiol Neurootol; 2021; 26(1):11-16. PubMed ID: 32535600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss.
    Lee JB; Choi SJ
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of intratympanic steroid therapy for severe and profound sudden sensorineural hearing loss.
    Aliyeva A; Edizer DT
    Am J Otolaryngol; 2024; 45(2):104170. PubMed ID: 38101127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and correlation between hearing outcomes after different episodes of recurrent idiopathic sudden sensorineural hearing loss.
    Wu PH; Lee CY; Chen HC; Lee JC; Chu YH; Cheng LH; Wang CH; Shih CP
    Auris Nasus Larynx; 2021 Oct; 48(5):870-877. PubMed ID: 33549393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Practice Guideline: Sudden Hearing Loss (Update).
    Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L
    Otolaryngol Head Neck Surg; 2019 Aug; 161(1_suppl):S1-S45. PubMed ID: 31369359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss.
    Covelli E; Altabaa K; Verillaud B; Camous D; Hautefort C; Barbara M; Herman P; Kania R
    Acta Otolaryngol; 2018 Nov; 138(11):966-971. PubMed ID: 30380957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis.
    Gao Y; Liu D
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3699-3711. PubMed ID: 27071771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.
    Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L; Monjur TM
    Otolaryngol Head Neck Surg; 2019 Aug; 161(2):195-210. PubMed ID: 31369349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.